Kroll to Sponsor and Speak at GIR Live: DC Spring 2023

Conference

March 23, 2023 | (Conference)

Paul Hastings Law Office, 2050 M Street NW, Washington, D.C., 20036

Kroll to Sponsor and Speak at GIR Live: DC Spring 2023

Kroll is excited to be an exclusive sponsor at GIR Live: DC Spring 2023. This interactive conference will bring together practitioners from across North America, including investigators, private practice lawyers, funders, expert witnesses and senior general counsel, to debate and analyze the latest major developments in investigations.

Managing Director Richard Faughnan will be speaking on the panel, Self-Disclosure and Compliance Monitors on March 23.

He will be joined by senior partners and corporate professionals to discuss the impact of recent legislative decisions on self-disclosure, including what makes self-disclosure a good decision, identifying the need for monitors and the DOJ’s plans to regulate monitors.

Our experts would love to meet with you and discuss how Kroll's range of data, investigative and forensic technology capabilities can help you stay ahead and mitigate risk.

Dive Deeper into Kroll’s Solutions

Client Story: Discover how Kroll’s Forensic Investigations, Cyber Risk, and Security Risk Management teams came together to help a client identify, investigate, and protect against C-suite level fraud and credit card abuse.


Data Insights and Forensics
Kroll uses data insights and forensic technology to help clients address complex compliance, regulatory and legal matters.

Forensic Investigations and Intelligence
Learn more about how Kroll provides clients with global investigative expertise to help make critical decisions and mitigate risk.

Client Story: Discover how Kroll’s Forensic Investigations, Cyber Risk, and Security Risk Management teams came together to help a client identify, investigate, and protect against C-suite level fraud and credit card abuse.


Meet our Kroll Experts


ServicesStay Ahead With Kroll

Investigations and Disputes

Investigations and Disputes

World-wide expert services and tech-enabled advisory through all stages of diligence, forensic investigation, litigation, disputes and testimony.

Forensic Investigations and Intelligence

Forensic Investigations and Intelligence

Kroll’s forensic investigations and intelligence team delivers actionable data and insights to help clients across the world make critical decisions and mitigate risk.

Data Insights and Forensics

Data Insights and Forensics

We are the leading advisors to organizations, providing expertise and solutions to address complex risks and challenges involving technology and data. We advise clients with services to address risks in disputes, investigations and regulatory compliance.

Compliance and Regulation

Compliance and Regulation

End-to-end governance, advisory and monitorship solutions to detect, mitigate and remediate security, legal, compliance and regulatory risk.

Corporate Finance and Restructuring

Corporate Finance and Restructuring

M&A advisory, restructuring and insolvency, debt advisory, strategic alternatives, transaction diligence and independent financial opinions.

Explore Our Client Stories

Tackling Online Abuse and Hate Speech

Risk Intelligence

Tackling Online Abuse and Hate Speech for an English Premier League Football Club

Tackling Online Abuse and Hate Speech for an English Premier League Football Club

In the midst of growing online abuse and hate speech, Kroll helps their partners by delivering fact-based, actionable risk intelligence to ensure the safety of their communities as well as overall reputation. Read more to find out how we did it.

COVID-19 Vaccine Rollout

Risk Intelligence

COVID-19 Vaccine Rollout: Stopping the Spread of Misinformation

COVID-19 Vaccine Rollout: Stopping the Spread of Misinformation

Learn more about how Kroll kept pace with the surge of digital chatter to discover, classify, report adverse events, and escalate harmful content in real time so that a U.S. biotech company could safely produce and distribute its life-saving Covid-19 vaccine.